News on TTR from BioPortfolio.com http://www.BioPortfolio.com Consolidated TTR news from BioPortfolio.com Wed, 10 Feb 2010 10:11:55 GMT en Alnylam to Webcast Presentation at The 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994981&HITNO=0&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994981&THISHREF=http://c.moreover.com/click/here.pl%3fz2515392818%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994981&HITNO=0&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994981&THISHREF=http://c.moreover.com/click/here.pl%3fz2515392818%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Alnylam to Webcast Presentation at The 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994586&HITNO=1&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994586&THISHREF=http://c.moreover.com/click/here.pl%3fz2515125773%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994586&HITNO=1&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994586&THISHREF=http://c.moreover.com/click/here.pl%3fz2515125773%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Alnylam to Webcast Presentation at The 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994387&HITNO=2&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994387&THISHREF=http://c.moreover.com/click/here.pl%3fz2515018172%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994387&HITNO=2&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994387&THISHREF=http://c.moreover.com/click/here.pl%3fz2515018172%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Alnylam to Webcast Presentation at The 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994141&HITNO=3&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994141&THISHREF=http://c.moreover.com/click/here.pl%3fz2514894315%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994141&HITNO=3&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994141&THISHREF=http://c.moreover.com/click/here.pl%3fz2514894315%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Alnylam And Collaborators Present Data From Multiple Pre-Clinical And Clinical Programs At RNAi Keystone Sympohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3939204&HITNO=4&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3939204&THISHREF=http://c.moreover.com/click/here.pl%3fz2484514396%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3939204&HITNO=4&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3939204&THISHREF=http://c.moreover.com/click/here.pl%3fz2484514396%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Alnylam and Collaborators Present Data from Multiple Pre-Clinical and Clinical Programs at RNAi Keystone Symposiumhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3932472&HITNO=5&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3932472&THISHREF=http://c.moreover.com/click/here.pl%3fz2481136501%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3932472&HITNO=5&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3932472&THISHREF=http://c.moreover.com/click/here.pl%3fz2481136501%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Alnylam and Collaborators Present Data from Multiple Pre-Clinical and Clinical Programs at RNAi Keystone Sympohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3934035&HITNO=6&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3934035&THISHREF=http://c.moreover.com/click/here.pl%3fz2482036161%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3934035&HITNO=6&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3934035&THISHREF=http://c.moreover.com/click/here.pl%3fz2482036161%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposiumhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933072&HITNO=7&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933072&THISHREF=http://c.moreover.com/click/here.pl%3fz2481480189%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933072&HITNO=7&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933072&THISHREF=http://c.moreover.com/click/here.pl%3fz2481480189%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Alnylam and Collaborators Present Data from Multiple Pre-Clinical and Clinical Programs at RNAi Keystone Symposiumhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931778&HITNO=8&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931778&THISHREF=http://c.moreover.com/click/here.pl%3fz2480697616%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931778&HITNO=8&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931778&THISHREF=http://c.moreover.com/click/here.pl%3fz2480697616%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Alnylam Pharma (ALNY) Presents Data from Multiple Clinical and Pre-Clinical Programshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931279&HITNO=9&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931279&THISHREF=http://c.moreover.com/click/here.pl%3fz2480435205%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931279&HITNO=9&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931279&THISHREF=http://c.moreover.com/click/here.pl%3fz2480435205%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Genzyme Reaches Agreement with Activist Investor, Charles River Closes Shrewsbury Lab, Lycera Comes to Cambridge, & More Boston-Area Life Sciences Newshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3899184&HITNO=10&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3899184&THISHREF=http://c.moreover.com/click/here.pl%3fz2463217143%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3899184&HITNO=10&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3899184&THISHREF=http://c.moreover.com/click/here.pl%3fz2463217143%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comXconomy: Alnylam Provides Key Goals and Guidance for Next 12 to 18 Monthshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3889422&HITNO=11&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3889422&THISHREF=http://c.moreover.com/click/here.pl%3fz2458731386%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3889422&HITNO=11&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3889422&THISHREF=http://c.moreover.com/click/here.pl%3fz2458731386%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Alnylam Provides Key Goals and Guidance for Next 12 to 18 Monthshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886411&HITNO=12&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886411&THISHREF=http://c.moreover.com/click/here.pl%3fz2457700888%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886411&HITNO=12&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886411&THISHREF=http://c.moreover.com/click/here.pl%3fz2457700888%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Alnylam Pharma (ALNY) Updates on Pipeline and Key Business Goals for Next 12 - 18 Monthshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886227&HITNO=13&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886227&THISHREF=http://c.moreover.com/click/here.pl%3fz2457666943%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886227&HITNO=13&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886227&THISHREF=http://c.moreover.com/click/here.pl%3fz2457666943%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Alnylam Provides Key Goals and Guidance for Next 12 to 18 Monthshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3885889&HITNO=14&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3885889&THISHREF=http://c.moreover.com/click/here.pl%3fz2457582056%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3885889&HITNO=14&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TTR&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3885889&THISHREF=http://c.moreover.com/click/here.pl%3fz2457582056%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: